Harrison David A, D'Amico Giovanna, Singer Mervyn
Intensive Care National Audit & Research Centre, Tavistock House, Tavistock Square, London, United Kingdom.
Crit Care Med. 2007 Jul;35(7):1703-8. doi: 10.1097/01.CCM.0000269031.13283.C8.
Severe acute pancreatitis, defined as pancreatitis with distant organ dysfunction, is a condition carrying a high mortality and morbidity. Current outcome prediction scores are based on small populations, usually from single specialist centers. Some scores cannot be applied until several days into hospital admission. We thus sought to develop a new and more sensitive outcome prediction score--the Pancreatitis Outcome Prediction (POP) Score--for these high-risk patients.
Retrospective cohort study of a large multicenter intensive care database.
One hundred fifty-nine U.K. intensive care units.
Participants were 2,462 patients admitted to intensive care units with severe acute pancreatitis.
None.
Demographic, physiologic, and biochemical data collected within the first 24 hrs of intensive care unit admission were used to develop a risk prediction score using logistic regression. The six variables with the strongest relationship to hospital outcome--arterial pH, age, serum urea, mean arterial pressure, PaO2/FIO2 ratio, and total serum calcium (in order of decreasing impact)--produced a model with a prognostic discrimination (area under the receiver operating characteristic curve = 0.838) superior to other models. These six factors were used to develop an objectively weighted multivariate prognostic score ranging from 0 to 40 points.
Prognostic stratification of patients with severe acute pancreatitis requiring intensive care offers a useful audit tool to gauge unit performance and improve delineation of subsets for prospective trials. Prospective validation of this new outcome prediction score is required, preferably in different countries. The validity of the POP Score for either hospital or intensive care admission could also be tested and assessed for superiority over existing scores.
重症急性胰腺炎被定义为伴有远隔器官功能障碍的胰腺炎,是一种死亡率和发病率都很高的疾病。目前的预后预测评分基于小规模人群,通常来自单一专科中心。有些评分要到入院几天后才能应用。因此,我们试图为这些高危患者开发一种新的、更敏感的预后预测评分——胰腺炎预后预测(POP)评分。
对一个大型多中心重症监护数据库进行回顾性队列研究。
159个英国重症监护病房。
2462例入住重症监护病房的重症急性胰腺炎患者。
无。
使用逻辑回归分析,将重症监护病房入院后最初24小时内收集的人口统计学、生理学和生化数据用于建立风险预测评分。与医院结局关系最密切的六个变量——动脉血pH值、年龄、血清尿素、平均动脉压、PaO2/FIO2比值和总血清钙(按影响程度递减顺序排列)——产生了一个预后判别模型(受试者工作特征曲线下面积=0.838),优于其他模型。这六个因素被用于建立一个客观加权的多变量预后评分,范围从0到40分。
对需要重症监护的重症急性胰腺炎患者进行预后分层,为评估科室绩效和改善前瞻性试验亚组的划分提供了一个有用的审核工具。需要对这个新的预后预测评分进行前瞻性验证,最好在不同国家进行。也可以测试和评估POP评分在医院或重症监护入院时的有效性,以及其相对于现有评分的优越性。